Presentation is loading. Please wait.

Presentation is loading. Please wait.

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda.

Similar presentations


Presentation on theme: "Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda."— Presentation transcript:

1 Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda A. Mehta, Alexander A. Vinks, Alexandra Filipovich, Jack Bleesing, Sonata Jodele, Michael B. Jordan, Rebecca Marsh, Richard Tarin, Stephanie Edwards, Deborah Fearing, Julia Lawrence, Stella M. Davies  Biology of Blood and Marrow Transplantation  Volume 16, Issue 10, Pages (October 2010) DOI: /j.bbmt Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Mean concentration-time profiles of micafungin (3 mg/kg dose) in pediatric HSCT patients (mean data points ± SD). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda."

Similar presentations


Ads by Google